Fifth Third Bancorp
GMAB icon

Fifth Third Bancorp’s Genmab GMAB Stock Holding History

Fifth Third Bancorp’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
47,181
-190
-0.4% -$5.05K ﹤0.01% 1542
2026
Q1 		$1.27M Sell
47,371
-1,296
-3% -$38.8K ﹤0.01% 1474
2025
Q4 		$1.5M Buy
48,667
+8,442
+21% +$263K ﹤0.01% 535
2025
Q3 		$1.23M Sell
40,225
-1,200
-3% -$29.2K ﹤0.01% 577
2025
Q2 		$856K Sell
41,425
-726
-2% -$14.9K ﹤0.01% 638
2025
Q1 		$825K Buy
42,151
+6,015
+17% +$126K ﹤0.01% 628
2024
Q4 		$754K Sell
36,136
-8,440
-19% -$185K ﹤0.01% 639
2024
Q3 		$1.09M Sell
44,576
-680
-2% -$18.2K ﹤0.01% 587
2024
Q2 		$1.14M Sell
45,256
-4,330
-9% -$123K ﹤0.01% 573
2024
Q1 		$1.48M Sell
49,586
-358
-0.7% -$10.5K 0.01% 517
2023
Q4 		$1.59M Sell
49,944
-2,028
-4% -$63.7K 0.01% 498
2023
Q3 		$1.83M Buy
51,972
+51,751
+23,417% +$1.97M 0.01% 457
2023
Q2 		$8.4K Hold
221
– – ﹤0.01% 2040
2023
Q1 		$8.35K Buy
221
+10
+5% +$384 ﹤0.01% 2166
2022
Q4 		$8.94K Sell
211
-30
-12% -$1.24K ﹤0.01% 2009
2022
Q3 		$8K Sell
241
-13
-5% -$456 ﹤0.01% 2019
2022
Q2 		$8K Buy
254
+67
+36% +$2.17K ﹤0.01% 2077
2022
Q1 		$7K Sell
187
-177
-49% -$6.08K ﹤0.01% 2177
2021
Q4 		$14K Hold
364
– – ﹤0.01% 1981
2021
Q3 		$16K Buy
364
+24
+7% +$1.08K ﹤0.01% 1858
2021
Q2 		$14K Hold
340
– – ﹤0.01% 1904
2021
Q1 		$11K Sell
340
-688
-67% -$25.9K ﹤0.01% 1979
2020
Q4 		$42K Buy
1,028
+480
+88% +$17.9K ﹤0.01% 1453
2020
Q3 		$20K Hold
548
– – ﹤0.01% 1570
2020
Q2 		$19K Buy
548
+187
+52% +$5.1K ﹤0.01% 1557
2020
Q1 		$8K Hold
361
– – ﹤0.01% 1777
2019
Q4 		$8K Buy
+361
New +$7.88K ﹤0.01% 1884

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fifth Third Bancorp's GMAB Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Genmab (GMAB) stake by 0.4% in Q2 2026, selling an estimated $5.05K and leaving 47,181 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

Fifth Third Bancorp first reported a position in GMAB in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.83M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Fifth Third Bancorp held 47,181 shares of Genmab worth $1.3M as of Q2 2026.
  • Fifth Third Bancorp sold 190 Genmab shares in Q2 2026, an estimated $5.05K.
  • Genmab made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1542 holding.
  • Fifth Third Bancorp first reported a position in Genmab in Q4 2019 and has held it in 27 quarters since.
  • Fifth Third Bancorp's Genmab position peaked at $1.83M in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.